NLM Logo

OL(1)p53 MeSH Supplementary Concept Data 2025


MeSH Supplementary
OL(1)p53
Unique ID
C086760
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C086760
Registry Numbers
CI002S7WH8
Previous Indexing
*OLIGODEOXYNUCLEOTIDES, ANTISENSE (1999-2007)
*OLIGONUCLEOTIDES, ANTISENSE (94-98)
Heading Mapped to
*Thionucleotides
Frequency
4
Note
a 20-mer synthetic phosphorothioate oligonucleotide with a sequence complementary to p53; used in Phase I clinical trial for the treatment of acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS)
Source
Antisense Res Dev 1993 Winter;3(4):383-90
Date of Entry
1994/05/13
Revision Date
2018/12/10
OL(1)p53 Preferred
page delivered in 0.004s